Immune Activation, Hypoxia and Vasoreaction in Sepsis of Pulmonary Versus Abdominal Origin
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Sepsis remains a common entity in critical care patients with remarkable mortality. Pulmonary and abdominal infections (with subsequent sepsis) are the most common in the ICU. Despite extended research activities, no differences in patient outcome or organ dysfunction were revealed.
Sepsis is a complex immune reaction phenomenon based on unbalanced activation and suppression. In addition to changes of cytokine levels and immune cell activity, underlying genetic reactions are present. For instance, expression of miRNA (as a potential important step of immune cell activation) is likely changed during systemic and local immune reactions.
The aim of this study is to perform a detailed assay of immune cell activation, to investigate the levels of pro- and antiinflammatory cytokines and the various expression of miRNA depending on the origin of infection in the two most common sides. This means in ICU patients with early pulmonary or abdominal sepsis as well as in healthy controls. Additionally, clinical parameters of organ function, current infection markers as CRP and procalcitonin, cardiovascular function and heart rate variability will be assessed. Parameters of local tissue perfusion in a dynamic testing during forearm ischemia and plasma adenosine concentration will be measured.
| Condition |
|---|
|
Sepsis |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Immune Activation, Hypoxia and Vasoreaction in Sepsis of Pulmonary Versus Abdominal Origin |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Patients with sepsis of pulmonary or abdominal origin with admission to the ICU in the first 48 hours of sepsis onset
Inclusion Criteria:
- sepsis (according to the criteria of the International Sepsis Definition Conference)
Exclusion Criteria:
- pregnancy
- malignancy
- corticoid therapy
- organ transplantation
- renal insufficiency with HD
Contacts and Locations| Contact: Timo Sturm, Dr. med. | 0621 383 ext 0 | timo.sturm@umm.de |
| Germany | |
| University Hospital Mannheim | Recruiting |
| Mannheim, Germany, 68167 | |
More Information
No publications provided
| Responsible Party: | Timo Sturm, Principal Investigator, University Hospital Mannheim |
| ClinicalTrials.gov Identifier: | NCT01530932 History of Changes |
| Other Study ID Numbers: | 2011-411M-MA |
| Study First Received: | November 9, 2011 |
| Last Updated: | October 17, 2012 |
| Health Authority: | Germany: Ethics Comission |
Keywords provided by University Hospital Mannheim:
|
sepsis tissue oxygenation tissue perfusion immune reaction |
Additional relevant MeSH terms:
|
Sepsis Toxemia Anoxia Infection Systemic Inflammatory Response Syndrome |
Inflammation Pathologic Processes Signs and Symptoms, Respiratory Signs and Symptoms |
ClinicalTrials.gov processed this record on May 19, 2013